Literature DB >> 16375718

Aging blunts ischemic-preconditioning-induced neuroprotection following transient global ischemia in rats.

Zhen He1, Julia E Crook, James F Meschia, Thomas G Brott, Dennis W Dickson, Michael McKinney.   

Abstract

The present study examines the hypothesis that aging defined by the 50% survival age compromises neuroprotection afforded by ischemic preconditioning (IPC). Sixty-four male F344 rats aged 4- and 24-months, respectively, were subjected to IPC, (3-min ischemia) or sham-surgery followed by 10-min (full) ischemia or sham-surgery 2 days later. There were 4 groups at each age: sham-surgery-sham-surgery (SS), preconditioning-sham-surgery (PS), preconditioning-ischemia (PI) and sham-surgery-ischemia (SI) groups. Assessments of histology and immunoreactivities of N-methyl-D-aspartic acid receptor 1 (NMDAr1) and caspase-3 active peptide (C3AP) in the hippocampal CA1 region were performed 8 days after full ischemia. The CA1 "living cell ratio" was greater in the aged SI group than in the young SI group (32+/-6% vs. 17+/-5%, p<0.05), whereas the degree of protection against full ischemia afforded by IPC was reduced in the aged compared with the young (53+/-17% vs. 241+/-25%, P<0.0001). The basal level of NMDAr1 immunofluorescence was significantly higher in young animals, while the numbers of C3AP-positive cells were greater in all three aged ischemic groups as compared to respective young groups (p<0.01, p=0.055 and p<0.05). A fourth method of assessing cell damage using Fluoro Jade C labeled degenerating neurons that were also intensively eosinophilic. Counts of Fluoro Jade C-positive cells were higher in the young SI group than in the aged SI group (P<0.05), suggesting that mechanisms of ischemic cell death may change with aging. In conclusion, aging alters mechanisms of ischemic cell death in CA1 neurons and ischemic tolerance mechanisms are blunted by aging.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16375718     DOI: 10.2174/156720205774962674

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  21 in total

Review 1.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

Review 2.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

Review 3.  Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke.

Authors:  Yuechun Wang; Cesar Reis; Richard Applegate; Gary Stier; Robert Martin; John H Zhang
Journal:  Exp Neurol       Date:  2015-04-18       Impact factor: 5.330

Review 4.  Is age a key factor contributing to the disparity between success of neuroprotective strategies in young animals and limited success in elderly stroke patients? Focus on protein homeostasis.

Authors:  Wei Yang; Wulf Paschen
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-28       Impact factor: 6.200

5.  Pharmacologic preconditioning: translating the promise.

Authors:  Jeffrey M Gidday
Journal:  Transl Stroke Res       Date:  2010-01-03       Impact factor: 6.829

6.  Is there a place for cerebral preconditioning in the clinic?

Authors:  Richard F Keep; Michael M Wang; Jianming Xiang; Ya Hua; Guohua Xi
Journal:  Transl Stroke Res       Date:  2010-01-14       Impact factor: 6.829

7.  Ischemic tolerance in an in vivo model of glutamate preconditioning.

Authors:  Yomna Badawi; Ranu Pal; Dongwei Hui; Elias K Michaelis; Honglian Shi
Journal:  J Neurosci Res       Date:  2014-11-25       Impact factor: 4.164

Review 8.  Clinical application of preconditioning and postconditioning to achieve neuroprotection.

Authors:  Cameron Dezfulian; Matthew Garrett; Nestor R Gonzalez
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

9.  Should the STAIR criteria be modified for preconditioning studies?

Authors:  Michael M Wang; Guohua Xi; Richard F Keep
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

10.  Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection.

Authors:  Aysan Durukan; Turgut Tatlisumak
Journal:  Exp Transl Stroke Med       Date:  2010-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.